Drug Channels

AUGUST 6, 2024

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

Drug Pricing 90

Drug Pricing Documentation Hospitals 90

Drug Channels

MARCH 15, 2022

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. Copyright © 2006-2022 Pembroke Consulting, Inc.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

JULY 21, 2020

Last week, I documented that nearly half of U.S. Hospitals are the primary 340B covered entities that engage with these specialty pharmacies. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. pharmacies now participate in the 340B Drug Pricing Program. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Documentation Hospitals 52

Drug Channels

OCTOBER 11, 2022

contains new data on hospital acquisitions and consolidation activity. There are loads of internal hyperlinks to help you navigate the document and customize it to your specific interests and priorities. Copyright © 2006-2022 Pembroke Consulting, Inc. Section 6.1.6. It offers 142 proprietary charts, exhibits, and data tables.

Biosimilars 74

Biosimilars Hospitals Pharmaceutical Manufacturing Documentation 74

Drug Channels

OCTOBER 5, 2021

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, lawyers, consultants, and more. FOUR FUN FACTS.

Biosimilars 75

Biosimilars Pharmaceutical Manufacturing Hospitals Documentation 75

Drug Channels

OCTOBER 13, 2020

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. Copyright © 2006-2020 Pembroke Consulting, Inc.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Hospitals Documentation Vaccines 40

Drug Channels

OCTOBER 10, 2023

Licenses for our DCI reports are regularly purchased by nearly every entity involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 40

Specialty Pharmacies Biosimilars Pharmaceutical Manufacturing Documentation 40